Skip to main content

Table3 Predictors of survival rate in LN + pancreatic tumors by competing risk regression

From: Comparable prevalence of distant metastasis and survival of different primary site for LN + pancreatic tumor

 

SHR

95% CI

P value

Age, years

 18–49

1 [Reference]

  

 50–59

0.93

0.83–1.04

0.210

 60–69

1.03

0.92–1.14

0.646

  ≥ 70

1.07

0.96–1.19

0.244

Sex

 Female

1 [Reference]

  

 Male

1.06

1.01–1.13

0.047

Race

 White

1 [Reference]

  

 Black

1.04

0.93–1.15

0.510

 Other

0.97

0.87–1.09

0.642

Marital status

 Never married

1 [Reference]

  

 Married

1.01

0.91–1.11

0.881

 Divorced/ widowed

1.05

0.94–1.18

0.368

Size, no. (%)

  ≤ 2 cm

1 [Reference]

  

  ≤ 4 cm

1.21

1.10–1.32

 < 0.001

  > 4 cm

1.29

1.16–1.43

 < 0.001

Differentiation

 Well

1 [Reference]

  

 Intermediate

1.36

1.22–1.52

 < 0.001

 Poor/undifferentiated

1.71

1.53–1.91

 < 0.001

 Missing

1.58

1.37–1.82

 < 0.001

Lymph node ratio

 1–25%

1 [Reference]

  

 26–50%

1.32

1.24–1.42

 < 0.001

  > 50%

1.76

1.61–1.93

 < 0.001

Number of malignant mass

 One

1 [Reference]

  

 More than one

0.46

0.39–0.54

 < 0.001

Distance metastasis

 No

1 [Reference]

  

 Yes

1.56

1.37–1.78

 < 0.001

Site

 Pancreatic bodytail

1 [Reference]

  

 Pancreatic head

1.08

0.98–1.187

0.087